LIVIVO - Search results -

Search results

Result 1 - 10 of total 42

Search options

Article ; Online: Trend in respiratory viruses' activity in the COVID-19 area.

Farfour, Éric / Rouabah, Lamia / Bargain, Pauline / Lecuru, Marion / Picard, Clément / Tcherakian, Colas / Maneglier, Benjamin / Juillet, Stéphanie Marque / Vasse, Marc

Annales de biologie clinique

2023 Volume 81, Issue 4, Page(s) 403–409

Abstract: Objectives: SARS-CoV-2 has impacted the detection of seasonal respiratory viruses. We retrospectively assessed the trend in the detection of 10 viruses in the COVID-19 area in 2 hospitals located in the Paris area.: Methods: All patients positive for ...

Abstract	Objectives: SARS-CoV-2 has impacted the detection of seasonal respiratory viruses. We retrospectively assessed the trend in the detection of 10 viruses in the COVID-19 area in 2 hospitals located in the Paris area. Methods: All patients positive for a respiratory virus in two hospitals from September 2016 to August 2021 were retrospectively included. The rate of RT-PCR positive for each virus was calculated for the 2020-2021 season and the 2019-2020 season in comparison to a baseline of 3 seasons, i.e. 2016-2017, 2017-2018, and 2018-2019. Results: Overall, 7,835 patients were tested positive from September 2016 to August 2021. The detection of respiratory virus dramatically falls on week-11 of 2020, as the number of RT-PCR performed. Then, 3 trends were identified: a) almost a disappearance for influenza; b) a 10-weeks delay in the seasonal outbreak for RSV; c) a persistence of circulation with variable activity for other viruses. In comparison to a baseline of three seasons (2016-2019), the rate of positive patients was lower during the 2020-2021 season for coronavirus (4.51% vs. 1.26%, P < 0.0001), adenovirus (1.93% vs. 1.34%, P = 0.14), bocavirus (0.58% vs. 0.11%, P = 0.08), and enterovirus (0.28% vs. 0.0%, P = 0.12). In contrast, the rate of hMPV-positive (1.92% vs. 2.83%, P = 0.03) and hPIV-positive (2.17% vs. 2.99%, P = 0.06) patients increased. Conclusions: The fall in the number of respiratory viruses detected might be related to the lower number of tests performed and the implementation of non pharmaceutical intervention (NPI). Then, all viruses except influenza are detected, probably as a consequence of high adherence to influenza vaccines. Despite, a lower number of tests being performed, the rate of hMPV-positive and hPIV-positive patients increased suggesting an active circulation of these viruses. Altogether, these findings suggest a persistent circulation of common respiratory viruses all over the COVID-19 era.
MeSH term(s)	Humans ; Infant ; Influenza, Human/epidemiology ; Retrospective Studies ; COVID-19/diagnosis ; COVID-19/epidemiology ; SARS-CoV-2 ; Viruses ; Respiratory Tract Infections/diagnosis ; Respiratory Tract Infections/epidemiology
Language	English
Publishing date	2023-10-20
Publishing country	France
Document type	Journal Article
ZDB-ID	418098-7
ISSN	1950-6112 ; 0003-3898
ISSN (online)	1950-6112
ISSN	0003-3898
DOI	10.1684/abc.2023.1827
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Ud II Zs.203: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Details ▾
- See ZB MED holdings
- Order with fees

Article: Transplantation pulmonaire.

Stern, Marc / Picard, Clément / Roux, Antoine

La Revue du praticien

2019 Volume 68, Issue 2, Page(s) 189–194

Abstract: Lung transplantation. Lung transplantation is one therapeutic option for selected patients with end stage respiratory insufficiency secondary mainly to emphysema, pulmonary fibrosis and cystic fibro sis. Because of increased number of graft proposals, ... ...

Title translation	Lung transplantation.
Abstract	Lung transplantation. Lung transplantation is one therapeutic option for selected patients with end stage respiratory insufficiency secondary mainly to emphysema, pulmonary fibrosis and cystic fibro sis. Because of increased number of graft proposals, priority access to transplantation for the more severe patients (High Emergency program) and the ex vivo reperfusion, the annual number of lung transplantations rose in France up to 371 in 2016. Global survival greatly improved at first because of perioperative and early mortality reduction. Then the main challenges for the long term survival are the prevention and treatment of graft rejection including its cellular/humoral and acute/chronic component and the improvement of the preventive immunosuppressive treatment taking into account its increased risk of infectious, proliferative and metabolic complications. At least, with appropriate evaluation of risk/ benefit balance, lung transplantation is associated not only with an increased survival but also with a clear improvement of the quality of life.
MeSH term(s)	France ; Graft Rejection ; Humans ; Lung Transplantation ; Pulmonary Fibrosis ; Quality of Life
Language	French
Publishing date	2019-02-05
Publishing country	France
Document type	Journal Article
ZDB-ID	205365-2
ISSN	2101-017X ; 0035-2640
ISSN (online)	2101-017X
ISSN	0035-2640
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Ua VI Zs.433: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: Lung Transplantation: CT Assessment of Chronic Lung Allograft Dysfunction (CLAD).

Brun, Anne-Laure / Chabi, Marie-Laure / Picard, Clément / Mellot, François / Grenier, Philippe A

Diagnostics (Basel, Switzerland)

2021 Volume 11, Issue 5

Abstract: Chronic lung allograft rejection remains one of the major causes of morbi-mortality after lung transplantation. The term Chronic Lung Allograft Dysfunction (CLAD) has been proposed to describe the different processes that lead to a significant and ... ...

Abstract	Chronic lung allograft rejection remains one of the major causes of morbi-mortality after lung transplantation. The term Chronic Lung Allograft Dysfunction (CLAD) has been proposed to describe the different processes that lead to a significant and persistent deterioration in lung function without identifiable causes. The two main phenotypes of CLAD are Bronchiolitis Obliterans Syndrome (BOS) and Restrictive Allograft Syndrome (RAS), each of them characterized by particular functional and imaging features. These entities can be associated (mixed phenotype) or switched from one to the other. If CLAD remains a clinical diagnosis based on spirometry, computed tomography (CT) scan plays an important role in the diagnosis and follow-up of CLAD patients, to exclude identifiable causes of functional decline when CLAD is first suspected, to detect early abnormalities that can precede the diagnosis of CLAD (particularly RAS), to differentiate between the obstructive and restrictive phenotypes, and to detect exacerbations and evolution from one phenotype to the other. Recognition of early signs of rejection is crucial for better understanding of physiopathologic pathways and optimal management of patients.
Language	English
Publishing date	2021-04-30
Publishing country	Switzerland
Document type	Journal Article ; Review
ZDB-ID	2662336-5
ISSN	2075-4418
ISSN	2075-4418
DOI	10.3390/diagnostics11050817
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Book ; Online: Fluid-particle suspension by gas release from a granular bed

Homan, Tess / Vidal, Valérie / Picard, Clément / Joubaud, Sylvain

2020

Abstract: We have studied experimentally particle suspension when injecting a gas at the bottom of an immersed granular layer confined in a Hele-Shaw cell. This work focuses on the dynamics of particles slightly denser than the surrounding fluid. The gas, injected ...

Abstract	We have studied experimentally particle suspension when injecting a gas at the bottom of an immersed granular layer confined in a Hele-Shaw cell. This work focuses on the dynamics of particles slightly denser than the surrounding fluid. The gas, injected at constant flow-rate, rises through the granular bed then forms bubbles which entrain particles in the above liquid layer. The particles settle down on the edges of the cell, avalanche on the crater formed at the granular bed free surface, and are further entrained by the continuous bubbling at the center. We report the existence of a stationary state, resulting from the competition between particle entrainment and sedimentation. The average solid fraction in the suspension is derived from a simple measurement of the granular bed apparent area. A phenomenological model based on the balance between particle lift by bubbles at the center of the cell and their settling on its sides demonstrates that most of the particles entrained by bubbles come from a global recirculation of the suspension.
Keywords	Physics - Fluid Dynamics ; Physics - Classical Physics
Subject code	660
Publishing date	2020-11-30
Publishing country	us
Document type	Book ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Clinical impact of TERT somatic mutation in telomerase-related gene mutation carriers after lung transplantation.

Ba, Ibrahima / Kannengiesser, Caroline / Mal, Hervé / Reynaud-Gaubert, Martine / Cottin, Vincent / Hirschi, Sandrine / Picard, Clément / Borie, Raphael

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

2022 Volume 41, Issue 9, Page(s) 1207–1209

Abstract: Almost 25% of patients with pulmonary fibrosis referred for lung transplantation have a germline rare variant of a telomere-related gene. Acquired TERT promoter mutations may counterbalanced the germline defect and reduce the risk of hematological ... ...

Abstract	Almost 25% of patients with pulmonary fibrosis referred for lung transplantation have a germline rare variant of a telomere-related gene. Acquired TERT promoter mutations may counterbalanced the germline defect and reduce the risk of hematological complications in this population. In a series of 34 patients with a germline telomere-related gene mutation who underwent lung transplantation, 12 (35%) patients had at least 1 acquired TERT promoter mutation. Six patients presented myelodysplasia before lung transplantation, with no difference between patients with and without an acquired TERT promoter mutation. After lung transplantation, myelodysplasia developed in only 1 of 8 patients with an acquired TERT promoter mutation versus 7 of 18 patients without a mutation. Survival did not differ between patients with and without an acquired mutation. The presence of an acquired TERT promoter mutation could be associated with reduced hematological complications after transplantation and with better outcome in telomere-related gene mutation carriers but requires further study.
MeSH term(s)	Heterozygote ; Humans ; Lung Transplantation ; Mutation ; Telomerase/genetics ; Telomerase/metabolism ; Telomere
Chemical Substances	TERT protein, human (EC 2.7.7.49) ; Telomerase (EC 2.7.7.49)
Language	English
Publishing date	2022-06-19
Publishing country	United States
Document type	Journal Article
ZDB-ID	1062522-7
ISSN	1557-3117 ; 1053-2498
ISSN (online)	1557-3117
ISSN	1053-2498
DOI	10.1016/j.healun.2022.06.012
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 2056: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Trans-arterial embolization for hemoptysis in lung transplant recipients.

Gravel, Guillaume / Sage, Edouard / Cuquemelle, Elise / Roussel, Alexandre / Roux, Antoine / Glorion, Matthieu / Parquin, François / Mellot, François / Picard, Clément

Respiratory medicine and research

2022 Volume 82, Page(s) 100941

Abstract: Introduction: Hemoptysis isn't rare in lung transplant recipients (LTR). Yet, trans-arterial embolization (TAE) in LTR has been rarely reported in the literature. The aim of the study was to present the feasibility and outcomes of TAE for hemoptysis in ... ...

Abstract	Introduction: Hemoptysis isn't rare in lung transplant recipients (LTR). Yet, trans-arterial embolization (TAE) in LTR has been rarely reported in the literature. The aim of the study was to present the feasibility and outcomes of TAE for hemoptysis in LTR. Materials and methods: Retrospective study of all LTR who underwent TAE for hemoptysis in our single institution between 2005 and 2020. Results: A total of 787 patients underwent lung transplantation between 2005 and 2020. Fifteen LTR underwent 21 TAE for hemoptysis in a median delay of 42 days after LT. TAE was performed within a year after LT in 13 patients (86.7%) with 12 of those patients having concomitant severe ischemic airway injury with necrosis and anastomotic dehiscence. Bronchoscopy confirmed bronchial anastomoses has being the source of the bleeding in 11 LTR (84.6%). Restoration of bronchial vascularization was highlighted in 13 patients (87%). Despite TAE, bronchial anastomosis healing was observed in all surviving patients with anastomotic dehiscence in a median delay of 43 days. Conclusion: In our experience, hemoptysis requiring TAE in LTR was rare, frequently occurring in the first weeks after LT, and seemed associated with anastomotic ischemia and dehiscence. Bleeding mainly originated from ischemic bronchial anastomosis through the restoration of the bronchial artery circulation. Our results suggest that bronchial arteriography should be routinely proposed in such patients in the event of hemoptysis.
MeSH term(s)	Humans ; Hemoptysis/etiology ; Hemoptysis/therapy ; Retrospective Studies ; Transplant Recipients ; Treatment Outcome ; Lung
Language	English
Publishing date	2022-07-28
Publishing country	France
Document type	Journal Article
ISSN	2590-0412
ISSN (online)	2590-0412
DOI	10.1016/j.resmer.2022.100941
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾
- Full text online
- Order with fees

Article ; Online: Center variability in the prognostic value of a cumulative acute cellular rejection "A-score" for long-term lung transplant outcomes.

Belousova, Natalia / Huszti, Ella / Li, Qixuan / Vasileva, Anastasiia / Ghany, Rasheed / Gabarin, Ramy / El Sanharawi, Moustapha / Picard, Clement / Hwang, David / Levy, Liran / Keshavjee, Shaf / Chow, Chung-Wai / Roux, Antoine / Martinu, Tereza

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

2023 Volume 24, Issue 1, Page(s) 89–103

Abstract: The acute rejection score (A-score) in lung transplant recipients, calculated as the average of acute cellular rejection A-grades across transbronchial biopsies, summarizes the cumulative burden of rejection over time. We assessed the association between ...

Abstract	The acute rejection score (A-score) in lung transplant recipients, calculated as the average of acute cellular rejection A-grades across transbronchial biopsies, summarizes the cumulative burden of rejection over time. We assessed the association between A-score and transplant outcomes in 2 geographically distinct cohorts. The primary cohort included 772 double lung transplant recipients. The analysis was repeated in 300 patients from an independent comparison cohort. Time-dependent multivariable Cox models were constructed to evaluate the association between A-score and chronic lung allograft dysfunction or graft failure. Landmark analyses were performed with A-score calculated at 6 and 12 months posttransplant. In the primary cohort, no association was found between A-score and graft outcome. However, in the comparison cohort, time-dependent A-score was associated with chronic lung allograft dysfunction both as a time-dependent variable (hazard ratio, 1.51; P < .01) and when calculated at 6 months posttransplant (hazard ratio, 1.355; P = .031). The A-score can be a useful predictor of lung transplant outcomes in some settings but is not generalizable across all centers; its utility as a prognostication tool is therefore limited.
MeSH term(s)	Humans ; Prognosis ; Retrospective Studies ; Lung Transplantation/adverse effects ; Lung ; Proportional Hazards Models ; Graft Rejection/diagnosis ; Graft Rejection/etiology
Language	English
Publishing date	2023-08-23
Publishing country	United States
Document type	Journal Article
ZDB-ID	2060594-8
ISSN	1600-6143 ; 1600-6135
ISSN (online)	1600-6143
ISSN	1600-6135
DOI	10.1016/j.ajt.2023.08.014
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 5542: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Results of Lung Transplantation for Cystic Fibrosis With Selected Donors Over 65 Years Old.

Glorion, Matthieu / Sarsam, Matthieu / Roux, Antoine / Stern, Marc / Belousova, Natalia / Fessler, Julien / Pricopi, Ciprian / De Wolf, Julien / Picard, Clement / Brugière, Olivier / De Miranda, Sandra / Grenet, Dominique / Tachon, Guillaume / Cerf, Charles / Parquin, Francois / Le Guen, Morgan / Chapelier, Alain / Vallée, Alexandre / Sage, Edouard

Transplant international : official journal of the European Society for Organ Transplantation

2023 Volume 36, Page(s) 11180

Abstract: Lung transplantation is limited by the shortage of suitable donors. Many programs have begun to use extended criteria donors. Donors over 65 years old are rarely reported, especially for young cystic fibrosis recipients. This monocentric study was ... ...

Abstract	Lung transplantation is limited by the shortage of suitable donors. Many programs have begun to use extended criteria donors. Donors over 65 years old are rarely reported, especially for young cystic fibrosis recipients. This monocentric study was conducted for cystic fibrosis recipients from January 2005 to December 2019, comparing two cohorts according to lung donor age (<65 years or ≥65 years). The primary objective was to assess the survival rate at 3 years using a Cox multivariable model. Of the 356 lung recipients, 326 had donors under 65 years, and 30 had donors over 65 years. Donors' characteristics did not differ significantly in terms of sex, time on mechanical ventilation before retrieval, and partial pressure of arterial oxygen/fraction of inspired oxygen ratio. There were no significant differences in post-operative mechanical ventilation duration and incidence of grade 3 primary graft dysfunction between the two groups. At 1, 3, and 5 years, the percentage of predicted forced expiratory volume in 1 s (
MeSH term(s)	Humans ; Aged ; Cystic Fibrosis/surgery ; Tissue and Organ Procurement ; Retrospective Studies ; Treatment Outcome ; Tissue Donors ; Lung Transplantation/methods ; Lung ; Oxygen
Chemical Substances	Oxygen (S88TT14065)
Language	English
Publishing date	2023-06-12
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	639435-8
ISSN	1432-2277 ; 0934-0874
ISSN (online)	1432-2277
ISSN	0934-0874
DOI	10.3389/ti.2023.11180
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 2358: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Conversion to belatacept after lung transplantation: Report of 10 cases.

Brugière, Olivier / Vallée, Alexandre / Raimbourg, Quentin / Peraldi, Marie-Noelle / de Verdière, Sylvie Colin / Beaumont, Laurence / Hamid, Abdulmonem / Zrounba, Mathilde / Roux, Antoine / Picard, Clément / Parquin, François / Glorion, Matthieu / Oniszczuk, Julie / Hertig, Alexandre / Mal, Hervé / Bunel, Vincent

PloS one

2023 Volume 18, Issue 3, Page(s) e0281492

Abstract: Background: Calcineurin inhibitors (CNIs) remain the cornerstone of maintenance immunosuppression (IS) after lung transplantation (LTx), although CNI-related life-threatening toxic effects may occur. Belatacept, a novel immunosuppressant that blocks a T- ...

Abstract	Background: Calcineurin inhibitors (CNIs) remain the cornerstone of maintenance immunosuppression (IS) after lung transplantation (LTx), although CNI-related life-threatening toxic effects may occur. Belatacept, a novel immunosuppressant that blocks a T-cell co-stimulation pathway, is a non-nephrotoxic drug indicated as an alternative to CNIs in kidney Tx. In LTx, there are only a few reports of belatacept conversion as a CNI-free or CNI-sparing IS treatment. Methods: We reviewed a series of 10 LTx recipients with conversion to a CNI-free belatacept IS regimen within the first year post-LTx (n = 7) or a belatacept/low-dose CNI combination after the first year (n = 3). Results: Use of belatacept was triggered by severe renal failure in 9 patients and under-IS with previous other IS-related toxicities in 1 patient. Mean estimated glomerular filtration rate after starting belatacept significantly improved at 6 months after initiation and at the last-follow-up (p = 0.006, and p = 0.002 respectively). The incidence of recurrent and/or severe acute cellular rejection (ACR) episodes was high in patients with CNI-free belatacept-based IS (n = 4/7). Chronic graft allograft dysfunction developed in 2 of 9 recipients under belatacept IS. Belatacept was stopped in 6 patients because of recurrent/severe ACR (n = 3), recurrent opportunistic infections (n = 1), center modified policy (n = 1), or other cause (n = 1). Conclusion: Early conversion to CNI-free belatacept-based IS improved renal function in this series but was counterbalanced by a high incidence of recurrent ACR, including life-threatening episodes. Other studies are needed to better determine the indications for its use after LTx, possibly with lower immunological risk IS regimens, such as CNI-sparing belatacept.
MeSH term(s)	Humans ; Abatacept/therapeutic use ; Abatacept/pharmacology ; Calcineurin Inhibitors/adverse effects ; Graft Rejection/drug therapy ; Graft Rejection/prevention & control ; Graft Survival ; Immunosuppressive Agents/adverse effects ; Kidney Transplantation/adverse effects ; Lung Transplantation/adverse effects
Chemical Substances	Abatacept (7D0YB67S97) ; Calcineurin Inhibitors ; Immunosuppressive Agents
Language	English
Publishing date	2023-03-15
Publishing country	United States
Document type	Journal Article
ZDB-ID	2267670-3
ISSN	1932-6203 ; 1932-6203
ISSN (online)	1932-6203
ISSN	1932-6203
DOI	10.1371/journal.pone.0281492
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: First use of imlifidase desensitization in a highly sensitized lung transplant candidate: a case report.

Roux, Antoine / Bunel, Vincent / Belousova, Natalia / Messika, Jonathan / Tanaka, Sebastien / Salpin, Mathilde / Roussel, Arnaud / Beaumont-Azuar, Laurence / Picard, Clement / Brugiere, Olivier / Devaquet, Jerome / Sage, Edouard / Le Guen, Morgan / Taupin, Jean-Luc / Devriese, Magali / Glorion, Mathieu / Parquin, Francois

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

2023 Volume 23, Issue 2, Page(s) 294–297

Abstract: Lung transplant candidates who are highly sensitized against human leucocyte antigen present an ongoing challenge with regards to finding immunologically acceptable donors. Desensitization strategies aimed at reducing preformed donor-specific antibodies ... ...

Abstract	Lung transplant candidates who are highly sensitized against human leucocyte antigen present an ongoing challenge with regards to finding immunologically acceptable donors. Desensitization strategies aimed at reducing preformed donor-specific antibodies have a number of limitations. Imlifidase, an IgG-degrading enzyme derived from Streptococcus pyogenes, is a novel agent that has been used to convert positive crossmatches to negative in kidney transplant candidates, allowing transplantation to occur. We present the first case of imlifidase use for antibody depletion in a highly sensitized lung transplant candidate who went on to undergo a successful bilateral lung transplant.
MeSH term(s)	Humans ; Antibodies ; Immunosuppressive Agents ; Kidney Transplantation/adverse effects ; Tissue Donors ; HLA Antigens ; Lung Transplantation/adverse effects ; Histocompatibility Testing ; Desensitization, Immunologic ; Graft Rejection/drug therapy ; Graft Rejection/etiology
Chemical Substances	Antibodies ; Immunosuppressive Agents ; HLA Antigens
Language	English
Publishing date	2023-01-12
Publishing country	United States
Document type	Case Reports
ZDB-ID	2060594-8
ISSN	1600-6143 ; 1600-6135
ISSN (online)	1600-6143
ISSN	1600-6135
DOI	10.1016/j.ajt.2022.11.025
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 5542: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

To top

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

Full text online

More links

Kategorien

Inter-library loan at ZB MED

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito